Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab
Conditions: Acute Lymphoblastic Leukemia Interventions: Drug: Blinatumomab Sponsors: Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Leukemia | Research | Stem Cell Therapy | Stem Cells | Study | Transplants